Production (Stage)
Endo, Inc.
NDOI
$20.85
-$0.05-0.24%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -15.97% | 9.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.97% | 9.61% | |||
| Cost of Revenue | -82.17% | 319.80% | |||
| Gross Profit | 165.11% | -264.92% | |||
| SG&A Expenses | 7.75% | -6.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -67.18% | 173.09% | |||
| Operating Income | 111.54% | -1,034.36% | |||
| Income Before Tax | 64.22% | -53.98% | |||
| Income Tax Expenses | 72.45% | -93.90% | |||
| Earnings from Continuing Operations | 63.18% | -50.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 63.18% | -50.06% | |||
| EBIT | 111.54% | -1,034.36% | |||
| EBITDA | 130.84% | -321.43% | |||
| EPS Basic | 63.20% | -50.06% | |||
| Normalized Basic EPS | 101.42% | -12,738.90% | |||
| EPS Diluted | 63.16% | -49.90% | |||
| Normalized Diluted EPS | 101.42% | -12,738.90% | |||
| Average Basic Shares Outstanding | 0.07% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.07% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||